According to InfuSystem's latest financial reports the company's current earnings (TTM) are $4.02 M. In 2022 the company made an earning of $1.53 M a decrease over its 2021 earnings that were of $2.63 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | $3.76 M | 145.89% |
2022 | $1.53 M | -41.84% |
2021 | $2.63 M | -70.06% |
2020 | $8.79 M | 156.65% |
2019 | $3.42 M | 806.88% |
2018 | $0.37 M | -109.63% |
2017 | -$3.93 M | -500.51% |
2016 | $0.98 M | -84.9% |
2015 | $6.49 M | -30.54% |
2014 | $9.34 M | 50.78% |
2013 | $6.19 M | 421.63% |
2012 | $1.18 M | -101.79% |
2011 | -$66.39 M | -51561.24% |
2010 | $0.12 M | -97.54% |
2009 | $5.25 M | -59.18% |
2008 | $12.86 M | -12.77% |
2007 | $14.74 M | -170.81% |
2006 | -$20.83 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
Premier PINC | $0.23 B | 5,664.11% | ๐บ๐ธ USA |
DexCom DXCM | $0.73 B | 18,072.10% | ๐บ๐ธ USA |
CorVel Corporation
CRVL | $95.09 M | 2,265.01% | ๐บ๐ธ USA |
Biolase
BIOL | -$18.24 M | -553.59% | ๐บ๐ธ USA |